South American Gold EBIT

South American Gold (SAGD) currently reports a EBIT of $-150K as of December 2018. That compares with $-460K in the prior-year period — up 66.5% year over year. That is below the Healthcare sector average of $23B. Use the charts on this page to explore South American Gold's EBIT history and peer comparisons.

South American Gold's EBIT increased from $-460K to $-150K — a 66.5% year-over-year increase (period ending December 2018). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

South American Gold's EBIT of $-150K is lower than the Healthcare sector average of $23B. That is roughly 100.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

South American Gold reported $-150K in EBIT as of December 2018. That compares with $-460K in the prior-year period — up 66.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current EBIT of $-150K, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $23B. From there, open related valuation or income-statement pages for South American Gold, and consider following SAGD for alerts when major investors trade the stock.